Supplement Guide | Fish Oil 02 | Why “Omega-3” Is an Oversimplification: EPA, DHA, and ALA Explained

This is part 2 of SuppCo’s four-part series on fish oil, covering its sources, health effects, quality considerations, and other key topics consumers should understand.

To read the first article in the series click here.

If you have ever compared two fish oil labels side by side, you have probably seen this problem play out in real time. One product lists 1,000 mg of omega-3s. Another lists 600 mg. A third highlights flaxseed oil as an omega-3 source. 

On the surface, these look like variations on the same theme. Biologically, they are not.

Omega-3 fatty acids are often discussed as if they represent a single nutrient category, but that framing breaks down quickly once you look at how these fats actually behave in the body. EPA, DHA, and ALA are structurally related, but they are metabolized differently, accumulate in different tissues, and are supported by very different bodies of evidence.

Understanding those differences is essential for interpreting labels, evaluating claims, and deciding whether food, supplements, or neither make sense for you.

The structural differences that drive everything else

All omega-3s share a defining feature, a double bond three carbons from the end of the fatty acid chain. Beyond that shared chemistry, they diverge in meaningful ways.

• ALA (alpha-linolenic acid) is an 18-carbon fatty acid found primarily in plant foods like flaxseed, chia, and walnuts.

• EPA (eicosapentaenoic acid) is a 20-carbon fatty acid found almost exclusively in marine sources.

• DHA (docosahexaenoic acid) is a 22-carbon fatty acid, also marine derived, with a highly flexible structure that makes it uniquely suited for cell membranes.

Those extra carbons and double bonds may seem minor, but they determine where each fatty acid is used, how long it stays in the body, and what physiological roles it can realistically support.

ALA: abundant in the diet, limited in conversion

ALA is the most common omega-3 in Western diets, largely because it is present in widely consumed plant oils and seeds. It is also where much of the confusion around omega-3s begins.

If you have ever assumed that eating enough ALA rich foods automatically raises EPA and DHA levels, you are not alone. The body can convert ALA into EPA and DHA, but this process is tightly regulated and inefficient.

Human studies consistently show that only a small fraction of dietary ALA becomes EPA, and conversion to DHA is typically well under 1 percent in adults. Sex, genetics, baseline omega-3 status, and overall diet can influence this pathway, but even under favorable conditions, ALA does not meaningfully replace marine omega-3 intake.

This does not mean ALA has no value. It appears to confer modest cardiovascular benefits through mechanisms that are likely independent of EPA and DHA. The key point is that ALA should not be treated as a functional substitute when tissue enrichment or specific EPA or DHA driven outcomes are the goal.

EPA: the inflammation and signaling specialist

EPA plays a central role in inflammatory regulation and vascular signaling. It serves as a precursor for eicosanoids and specialized pro-resolving mediators that help shape immune responses and endothelial function.

This is where many people first encounter EPA clinically, often through triglyceride lowering or cardiovascular risk discussions. EPA has been consistently associated with:

• Reductions in triglyceride levels

• Modulation of inflammatory biomarkers

• Cardiovascular risk reduction in select populations

Notably, several of the strongest cardiovascular outcome trials have relied on high dose EPA rather than mixed omega-3 formulations. This has reinforced an important lesson, total omega-3 intake alone does not predict biological effect.

EPA also tends to remain more active in circulation, which likely explains why its effects show up more reliably in blood based markers.

DHA: the structural omega-3

If EPA is primarily about signaling, DHA is about structure.

DHA is a dominant fatty acid in the brain, retina, and other neural tissues, where its flexible structure supports membrane fluidity, receptor function, and synaptic signaling. Once DHA is incorporated into cell membranes, it turns over slowly, meaning changes in DHA status reflect long term intake rather than short term dosing.

DHA has been most strongly linked to:

• Neurodevelopment and cognitive maintenance

• Visual function

• Structural integrity of neural and retinal tissues

This slower turnover also helps explain why DHA effects are often less obvious in standard blood markers, but more relevant for long term neurological and visual outcomes.

Why “total omega-3s” on labels miss the point

If you have ever wondered why two fish oil products with the same total omega-3 content can produce very different results, now you know.

Many labels emphasize total omega-3s without clearly distinguishing EPA from DHA. From a scientific perspective, that number alone is of limited value. 

A product higher in EPA may be better suited for triglyceride lowering or inflammatory modulation. A product higher in DHA may be more appropriate for cognitive or visual support.

Without understanding that breakdown, comparisons become misleading and expectations drift away from what the biology can actually deliver.

The takeaway

EPA, DHA, and ALA are related, but they are not interchangeable. Treating them as a single nutrient category oversimplifies the science and leads to poor decision making around diet, supplementation, and outcomes.

In the next article, we will move from biochemistry to practical application, when food is enough, when supplements make sense, and how dosing works in the real world rather than on labels.

Knowing which omega-3 you are getting is the first step. Knowing when you actually need it is the next.